SubHero Banner
Text

February 2023

Core topics in this month’s edition include:

  • Lamzede (Vemanase alfa-tycv) – new orphan drug approval
  • Latuda (lurasidone) – first time generic
  • Heparin sodium injection recall

Download PDF

Text